FDA Withdraws Approvals For Advicor, Simcor At Request Of Manufacturer AbbVie
WASHINGTON, D.C. — The Food and Drug Administration said April 18 that it has withdrawn its approval of the cholesterol drugs Advicor and Simcor at the request of manufacturer AbbVie Inc....To view the full article, register now.
Already a subscriber? Click here to view full article